Aktieanalys

Respiratorius: Focusing on VAL001 - Redeye

{newsItem.title}

Redeye Publicerad: 07 Jun 2022 10:50

Redeye returns with an updated assessment of Respiratorius as its divestment of RCD405 and other COPD assets transform the company into a pure orphan oncology case on the verge of a potential near-term deal with key asset VAL001.

Länk till analysen i sin helhet: https://www.redeye.se/research/844382/respiratorius-focusing-on-val001?utm_source=finwire&utm_medium=RSS

Nyheter om Respiratorius

Läses av andra just nu

Om aktien Respiratorius

Senaste nytt